These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8093685)
1. PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors. Keim DR; Hailat N; Kuick R; Reynolds CP; Brodeur GM; Seeger RC; Hanash SM Clin Exp Metastasis; 1993 Jan; 11(1):83-90. PubMed ID: 8093685 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of proliferating cell nuclear antigen (PCNA) immunostaining in neuroblastoma. Kawasaki H; Mukai K; Yajima S; Tanaka R; Takayama J; Takasaki Y; Ohira M Med Pediatr Oncol; 1995 May; 24(5):300-4. PubMed ID: 7700181 [TBL] [Abstract][Full Text] [Related]
3. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991 [TBL] [Abstract][Full Text] [Related]
4. Hsp27 expression in neuroblastoma: correlation with disease stage. Ungar DR; Hailat N; Strahler JR; Kuick RD; Brodeur GM; Seeger RC; Reynolds CP; Hanash SM J Natl Cancer Inst; 1994 May; 86(10):780-4. PubMed ID: 8169976 [TBL] [Abstract][Full Text] [Related]
5. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. Hailat N; Keim DR; Melhem RF; Zhu XX; Eckerskorn C; Brodeur GM; Reynolds CP; Seeger RC; Lottspeich F; Strahler JR J Clin Invest; 1991 Jul; 88(1):341-5. PubMed ID: 2056128 [TBL] [Abstract][Full Text] [Related]
6. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746 [TBL] [Abstract][Full Text] [Related]
7. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334 [TBL] [Abstract][Full Text] [Related]
8. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma. Mejía C; Navarro S; Colamonici OR; Pellín A; Castel V; Llombart-Bosch A Oncol Rep; 1999; 6(1):149-53. PubMed ID: 9864419 [TBL] [Abstract][Full Text] [Related]
9. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933 [TBL] [Abstract][Full Text] [Related]
10. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847 [TBL] [Abstract][Full Text] [Related]
11. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview. Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015 [TBL] [Abstract][Full Text] [Related]
13. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868 [TBL] [Abstract][Full Text] [Related]
14. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Hailat N; Strahler J; Melhem R; Zhu XX; Brodeur G; Seeger RC; Reynolds CP; Hanash S Oncogene; 1990 Nov; 5(11):1615-8. PubMed ID: 2267130 [TBL] [Abstract][Full Text] [Related]
15. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310 [TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region. Hiyama E; Hiyama K; Yokoyama T Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381 [TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963 [TBL] [Abstract][Full Text] [Related]
18. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Martinsson T; Sjöberg RM; Hedborg F; Kogner P Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654 [TBL] [Abstract][Full Text] [Related]
19. Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected human neuroblastoma. Sugio K; Nakagawara A; Sasazuki T Cancer; 1991 Mar; 67(5):1384-8. PubMed ID: 1991301 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural localization and fluctuation in the level of the proliferating cell nuclear antigen and myc oncoproteins in synchronized neuroblastoma cells. Gazitt Y; Erdos GW; Cohen RJ Cancer Res; 1993 Apr; 53(8):1899-905. PubMed ID: 8096797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]